Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2008
08/26/2008US7417021 Biologically active conjugate of a biopolymer and therapeutic agent
08/26/2008US7416887 Preparing viable stem cells in culture; prepare nutrient broth containing ligand and preferential receptor, inoculate with cells, monitor propagation and viability of cells
08/26/2008US7416877 Type I transmembrane; cytokine receptor proteins having immunoregulatory activity; isolated DNA, recombinant expression vectors, transformed or transfected cells, monoclonal antibodies
08/26/2008US7416874 For use in food and feeds
08/26/2008US7416864 Method for treating dyskinesia
08/26/2008US7416861 Human coagulation factor VII polypeptides
08/26/2008US7416860 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins
08/26/2008US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
08/26/2008US7416855 Comprises nucleotide sequences coding enzymatic polypeptide associated with programed cell death for identifying modulators for treatment of inflammatory, neurodegenerative and cell proliferative disorders
08/26/2008US7416853 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/26/2008US7416849 HBM variants that modulate bone mass and lipid levels
08/26/2008US7416745 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
08/26/2008US7416734 Vaccines for Mycoplasma bovis and methods of use
08/26/2008US7416733 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins
08/26/2008US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein.
08/26/2008US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use
08/26/2008US7416729 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen
08/26/2008US7416728 Growth blocking agents
08/26/2008US7416726 Cytotoxicity; therapeutic antibody
08/26/2008US7416725 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
08/26/2008US7416724 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
08/26/2008US7416723 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/26/2008CA2441535C Methods for delivering nucleic acid molecules into cells and assessment thereof
08/26/2008CA2374667C Synthetic ligation reassembly in directed evolution
08/26/2008CA2277112C Use of exendins and agonists thereof for the reduction of food intake
08/26/2008CA2235225C Nima interacting proteins
08/26/2008CA2171550C Nucleosides with anti-hepatitis b virus activity
08/26/2008CA2159602C Stable liquid compositions of gamma interferon
08/21/2008WO2008101179A2 Use of sucrose to suppress mannitol-induced protein aggregation
08/21/2008WO2008101175A2 Protein formulations containing sorbitol
08/21/2008WO2008101154A2 Immunotherapy for immune suppressed patients
08/21/2008WO2008101104A2 Aligned nanofibers and related methods of use
08/21/2008WO2008101098A2 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis
08/21/2008WO2008101084A2 Methods and compositions for the disruption of biofilms
08/21/2008WO2008101060A1 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
08/21/2008WO2008100627A2 The secreted protein ccdc80 regulates adipocyte differentiation
08/21/2008WO2008100609A1 A novel antitoxin and vaccine platform based on nodavirus vlps
08/21/2008WO2008100591A2 Modulation of nitric oxide signaling to normalize tumor vasculature
08/21/2008WO2008100498A2 Treatment of inflammatory diseases using placental stem cells
08/21/2008WO2008100450A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
08/21/2008WO2008100449A2 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
08/21/2008WO2008100384A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients
08/21/2008WO2008100328A2 METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32
08/21/2008WO2008100288A2 High affinity ephb receptor binding compounds and methods of use thereof
08/21/2008WO2008100258A1 Intraperitoneal administration of antithrombin iii, related compositions and methods
08/21/2008WO2008100220A1 Compositions for increasing body weight, use and methods
08/21/2008WO2008100140A1 Treatment of trauma hemorrhage with short oligopeptides
08/21/2008WO2008100130A2 Composition containing kadok extract and collagen
08/21/2008WO2008100061A1 Novel use of hiv nc protein
08/21/2008WO2008099928A1 Placental protein having action of regulating protease activity and its related gene
08/21/2008WO2008099908A1 Vaccine therapy for choroidal neovascularization
08/21/2008WO2008099829A1 Method for formation of intestinal adhesion in experimental animal, method for production of experimental animal having intestinal adhesion, method for screening of intestinal adhesion-preventing agent, and intestinal adhesion-preventing agent
08/21/2008WO2008099742A2 Ejection liquid and ejection method
08/21/2008WO2008099561A1 Agent for promoting cell proliferation using antimicrobial peptide and method for promoting cell proliferation using serum-free medium containing the same
08/21/2008WO2008099190A2 Osteogenic compounds
08/21/2008WO2008099174A1 Wnt3a for inhibition of scarring
08/21/2008WO2008099170A1 Use of wnt3a for acceleration of wound healing
08/21/2008WO2008099084A1 Parenteral pharmaceutical composition and method for preparing the same
08/21/2008WO2008098796A1 Polypeptide comprising a knottin protein moiety
08/21/2008WO2008098720A1 Therapeutic application of kazal-type serine protease inhibitors
08/21/2008WO2008098379A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
08/21/2008WO2008098377A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/21/2008WO2008098368A1 Inhibitors of hepatitis c ns3 protease
08/21/2008WO2008098364A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
08/21/2008WO2008098355A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
08/21/2008WO2008098308A1 Agents and methods for treatment of cell proliferative diseases and conditions
08/21/2008WO2008098280A1 Methods for the synthesis of dicarba bridges in growth hormone peptides
08/21/2008WO2008079400A3 Surgical applications for bmp binding protein
08/21/2008WO2008078167A3 Consensus peptide
08/21/2008WO2008076370A9 P21 compositions and methods for the treatment of hiv
08/21/2008WO2008075349B1 Therapeutic methods using a thymus peptide
08/21/2008WO2008054464A3 Broad spectrum immune and antiviral gene modulation by oral interferon
08/21/2008WO2008039984A3 Methods and compositions for treating conditions by inhibiting cathepsin d
08/21/2008WO2008039173A3 Methods and compositions for inhibiting cell death or enhancing cell proliferation
08/21/2008WO2008021322A3 Selective alpha particle-mediated depletion of tumor vasculature with vascular normalization
08/21/2008WO2008019143A9 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition
08/21/2008WO2008005084B1 Methods to prevent and treat diseases
08/21/2008WO2007144196A3 Peptide compounds for treating refractory status epilepticus
08/21/2008WO2007120614A3 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation
08/21/2008WO2007109110A3 Methods for increasing the size of animals using needleless delivery constructs
08/21/2008WO2007101698A3 Modified molecules which promote hematopoiesis
08/21/2008WO2007100695A3 Metabolic regulators and uses thereof
08/21/2008WO2007088418A9 Drug-eluting intravascular prostheses and methods of use
08/21/2008WO2007084158A3 Novel use
08/21/2008WO2007070672A3 Non-natural amino acids and neurotensin analogues thereof
08/21/2008US20080201789 Variants and exons of the glyt1 transporter
08/21/2008US20080200848 Vibrating Device For Treating Nasal Congestion and Sinusitis Symptoms and Method Thereof
08/21/2008US20080200664 Nucleotide sequences coding transcription factor (p63) for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/21/2008US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
08/21/2008US20080200563 Non-invasive administering active materials; absorption iimproved using glutathione with active material; matric tablets, capsules
08/21/2008US20080200511 Novel Compounds and Methods of Using the Same
08/21/2008US20080200447 Neurotherapeutic Compositions and Method
08/21/2008US20080200436 Antiangiogenic and/or vascular permeability reducing effect; cancer, solid tumors; kits
08/21/2008US20080200414 HCaRG, A Novel Calcium-Regulated Gene
08/21/2008US20080200413 Oligonucleotide sequences which bind biomolecules such as peptides; selectively bind coagulation factors, E2F family members, Ang1 or Ang2; hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals
08/21/2008US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder
08/21/2008US20080200410 Kits containing primers or probes; amplification and/or hybridization; early diagnosis of neoplastic disease
08/21/2008US20080200400 Sequence of 4, 5 or 6 amino acids and derivative; dipeptide sequence Ile-Pro, Pro-Ile or combination; aging skin, atrophy, dryness, roughness, development of wrinkles, loss of elasticity, pigment irregularities
08/21/2008US20080200399 Taurine, cysteic acid residue and residue of a protease or calpain inhibitor; directly, indirectly bonded to each other;leucyl argininal residues in form of aldehyde; effective to inhibit calpains; acetal prodrug residues can be converted to the aldehyde form before, during, or after administration
08/21/2008US20080200398 Compounds For Enzyme Inhibition
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 3163